HTA92 Diffusion and launch sequencing of cell and gene therapies across the USA, Europe, Canada and Australia

Bergsteedt, Matthew, Tolkmitt, Fiona, Mills, Mackenzie and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2025) HTA92 Diffusion and launch sequencing of cell and gene therapies across the USA, Europe, Canada and Australia. Value in Health, 28 (6, Supplement 1). S263 - S264. ISSN 1098-3015

Full text not available from this repository.

Identification Number: 10.1016/j.jval.2025.04.1103

Abstract

Cell and gene therapies (CGTs) represent a significant advancement in healthcare, providing potential cures for previously untreatable conditions. However, they often carry high prices and their availability across settings remains mixed. This study examines the diffusion of FDA approved CGTs in Canada, Australia, France, Germany, England and Scotland.

Item Type:	Article
Additional Information:	© 2025 Published by Elsevier Inc.
Divisions:	Health Policy
Subjects:	R Medicine > RA Public aspects of medicine R Medicine > RM Therapeutics. Pharmacology
Date Deposited:	17 Jul 2025 10:30
Last Modified:	11 Sep 2025 12:28
URI:	http://eprints.lse.ac.uk/id/eprint/128862

Actions (login required)

View Item